Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 11.60B
March 31, 2026 11.66B
December 31, 2025 11.79B
September 30, 2025 11.68B
June 30, 2025 12.78B
March 31, 2025 12.33B
December 31, 2024 12.11B
September 30, 2024 12.84B
June 30, 2024 12.69B
March 31, 2024 12.76B
December 31, 2023 12.97B
September 30, 2023 12.80B
June 30, 2023 13.06B
March 31, 2023 13.40B
December 31, 2022 13.46B
September 30, 2022 13.11B
June 30, 2022 13.43B
March 31, 2022 13.84B
Date Value
December 31, 2021 13.90B
September 30, 2021 12.20B
June 30, 2021 11.25B
March 31, 2021 9.739B
December 31, 2020 9.906B
September 30, 2020 9.938B
June 30, 2020 9.867B
March 31, 2020 9.786B
December 31, 2019 9.773B
September 30, 2019 9.763B
June 30, 2019 10.02B
March 31, 2019 10.01B
December 31, 2018 9.912B
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 10.45B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 2.057B
Champions Oncology, Inc. 26.99M
Personalis, Inc. 312.14M
Adaptive Biotechnologies Corp. 640.68M
10X Genomics, Inc. 1.030B

Total Assets (Quarterly) Related Metrics